Evidence map›Paper›PMID 28255002›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Antibody-Mediated Rejection Due to Preexisting versus

Olivier Aubert, Alexandre Loupy, Luis Hidalgo, Jean-Paul Duong van Huyen, Sarah Higgins, Denis Viglietti, Xavier Jouven, Denis Glotz, Christophe Legendre, Carmen Lefaucheur and 1 more

2 registry-linked trialsOpen access · bronzeAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
20.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01299168 recruitingnot on this map

Multi-centric Observational Study to Analyse the Diagnostic Molecular Features in the Clinical Setting of Kidney Allograft Biopsies

TypeobservationalSponsorUniversity of AlbertaRan2011 to 2028Enrolled500ConditionsValidation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards
NCT05335538 unknown statusnot on this mapstarted 2021, after this paper: background citation

The Role of TruGraf® to Optimize Outcomes in Pediatric Renal Transplantation

TypeobservationalSponsorTransplant Genomics, Inc.Ran2021 to 2023Enrolled75ConditionsKidney Transplant RejectionArmsPatients monitored with TruGraf and TRAC testing
3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 244 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Trial
  4. Review
  5. Tailoring HLA antibody monitoring post-transplantation.Pediatric nephrology (Berlin, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. PreformedWorld journal of transplantation · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Noninvasive Diagnosis of Kidney Allograft Rejection.Journal of the American Society of Nephrology : JASN · 2025
    Review
  18. Article
  19. Article
  20. Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 5 countries.

Olivier AubertParis Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S970, Paris, France.
Alexandre LoupyParis Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S970, Paris, France; alexandreloupy@gmail.com.
Luis HidalgoDepartment of Laboratory Medicine and Pathology and.
Jean-Paul Duong van HuyenDepartment of Pathology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Sarah HigginsDepartment of Nephrology, Sherbrooke University, Sherbrooke, Québec, Canada; and.
Denis VigliettiParis Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S970, Paris, France.
Xavier JouvenParis Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S970, Paris, France.
Denis GlotzParis Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S970, Paris, France.
Christophe LegendreParis Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S970, Paris, France.
Carmen LefaucheurParis Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S970, Paris, France.
Philip F HalloranAlberta Transplant Applied Genomics Centre, Edmonton, Alberta, Canada.
Inserm · FRHôpital Saint-Louis · FRAssistance Publique – Hôpitaux de Paris · FRKidney Associates · USThe Metabolomics Innovation Centre · CAUniversité de Sherbrooke · CAUniversité Paris Cité · FRUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody-mediated rejection (ABMR) can occur in patients with preexisting anti-HLA donor-specific antibodies (DSA) or in patients who develop

Indexed as

Kidney TransplantationAllograftsAntibodiesAntibody SpecificityFemaleGraft RejectionHLA AntigensHumansKidney Failure, ChronicMaleMiddle AgedTissue DonorsAntibodiesHLA Antigensantibody-mediated rejectiondonor-specific anti-HLA antibodykidney transplantationmicroscopemoleculartransplant outcomes

Identifiers

PMID28255002
PMCPMC5461792
OpenAlexW2592185057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.